ARCHIVES

Nader Group Backs FDA In controversy Over Drug Testing

This article is from The Cancer Letter archive.

Vol. 03 No. 06 | February 11, 1977

Download PDF Visit The Full Archive

Related Articles

Brown Disagrees With Staff, Subgroup On Dichlorvos, Says It Is a Carcinogen

September 2, 1977

NCI Programs: Contract Awarded For Geographic Information System

May 14, 1999

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

February 22, 2008

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013

Senate Kills Plan to Increase Tax On Higher Tar, Nicotine Cigarettes

August 13, 1976

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

October 3, 2014